There is no correlation between high-density lipoprotein cholesterol (HDL-C) levels and a patient's risk for developing ...

There is no correlation between high-density lipoprotein cholesterol (HDL-C) levels and a patient's risk for developing ...

The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...

The two new locally acquired cases are from the same area where the first case was reported last week. In other state news: vaccine hesitancy and the Minnesota measles outbreak; an "epidemic" of ...

When states legalize medical and recreational cannabis, fewer prescriptions for anxiety are filled, but more for depression ...

Data from the federal government shows that Mississippi consistently ranks in the top five in the nation for its rates of ...

The use of antipsychotics for schizophrenia was associated with higher risk for severe cases of COVID-19 and non–COVID-19 respiratory infections but not mild infection.

This isn't the case for the other classes of medications that we included. We actually find suggestive evidence that cannabis ...

anti-anxiety medications, antipsychotics, stimulants, and mood stabilizers. These categories of medications are generally taken orally (by mouth). However, some categories mentioned above have varying ...

Although it might be an interesting study, there aren’t any randomized, controlled trials of antipsychotic medications for ...

Opens in a new tab or window Any patient on a dopamine receptor-blocking medication may develop tardive dyskinesia (TD), though most often the condition is associated with antipsychotic medications.